Glioblastoma, IDH-wildtype, with a novel MEF2D-NTRK1 gene fusion: a case report - Top-Institutions - MDSpire

Glioblastoma, IDH-wildtype, with a novel MEF2D-NTRK1 gene fusion: a case report

  • By

  • Anaya Dewey

  • Joaquina C. Baranda

  • Wei Zhang

  • Mohammad Haeri

  • Brian Milligan

  • Tolga Tuncer

  • May 28, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University of Texas MD Anderson Cancer Center
    University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Neuro-Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology
    • Neuro-Oncology

  • #3

    National Cancer Institute
    National Cancer Institute

    Bethesda, Maryland

    Key Differentiators

    • Oncology

  • #4

    University Hospital Heidelberg
    University Hospital Heidelberg

    Heidelberg, Germany

    Key Differentiators

    • Oncology

  • #5

    European C4CMMRD consortium
    European C4CMMRD consortium

    Various, Europe

    Key Differentiators

    • Oncology

Original Source(s)

Glioblastoma, IDH-wildtype, with a novel MEF2D-NTRK1 gene fusion: a case report

  • by Anaya Dewey, Joaquina C. Baranda, Wei Zhang, Mohammad Haeri, Brian Milligan, Tolga Tuncer

  • May 28, 2026

Related Content

FOXA2 in cancer: from fundamental biology to clinical translation

Percutaneous nephrostomy as a marker of clinical vulnerability in non-metastatic muscle-invasive bladder cancer: prognostic and infectious implications

Differentiation of hepatocellular carcinoma from hepatic hemangioma using diffusion-derived vessel density map-based radiomics features